◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Sanofi India Limited (SANOFI) Financial History

Name: Sanofi India Limited (SANOFI) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - General · DATA UPDATED 2026-09-20

Sanofi India Limited (SANOFI) operates in the Drug Manufacturers - General industry and is headquartered in Mumbai, India with about 1,097 employees. Its market capitalization is roughly ₹71 billion. In the fiscal year ended 2025-12-31, SANOFI reported ₹18.2B in revenue and ₹3.3B in net income.

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.

Interactive charts & full statements →

SANOFI Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	₹18.2B	₹19.9B	₹19.8B	₹27.3B	—
Gross Profit	₹9.2B	₹9.9B	₹10.1B	₹14.8B	—
Operating Income (EBIT)	₹4.5B	₹4.5B	₹4.5B	₹6.7B	—
Net Income	₹3.3B	₹4.1B	₹6.0B	₹6.2B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SANOFI Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-06-30	2025-03-31	2024-12-31
Total Revenue	₹4.4B	₹4.7B	₹4.2B	₹4.1B	₹5.4B	—
Gross Profit	₹2.1B	₹2.4B	₹2.1B	₹2.0B	₹3.0B	—
Operating Income (EBIT)	₹1.1B	₹1.3B	₹808M	₹858M	₹1.6B	—
Net Income	₹835M	₹1.0B	₹617M	₹695M	₹1.2B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SANOFI Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(₹4.4B)	(₹3.8B)	(₹8.7B)	(₹15.7B)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SANOFI Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	₹12.5B	₹16.1B	₹17.1B	₹20.7B	—
Total Liabilities	₹5.1B	₹7.5B	₹7.0B	₹8.0B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SANOFI viewer.

Other Companies in Drug Manufacturers - General

PFIZER · Pfizer Limited — ₹183 billion
MARKSANS · Marksans Pharma Limited — ₹145 billion
1093 · CSPC Pharmaceutical Group Limited — HK$102 billion
SANOFICONR · Sanofi Consumer Healthcare India Limited — ₹93 billion
SYMBIOTEC · SYMBIOTEC PHARMALAB LTD — ₹70 billion
SENORES · Senores Pharmaceuticals Limited — ₹65 billion
4552 · JCR Pharmaceuticals Co., Ltd. — JPY 63 billion
BAYN · Bayer Aktiengesellschaft — €47 billion

← SANO1 All “S” companies SANOFICONR →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.